Stratec SE (VIE:SBSG)

Market Cap	286.27M
Revenue (ttm)	260.25M
Net Income (ttm)	15.36M
Shares Out	n/a
EPS (ttm)	1.26
PE Ratio	18.64
Forward PE	16.86
Dividend	0.60 (2.56%)
Ex-Dividend Date	Jun 30, 2025

Volume	n/a
Average Volume	n/a
Open	23.70
Previous Close	24.20
Day's Range	23.20 - 23.70
52-Week Range	19.78 - 32.65
Beta	n/a
RSI	59.98
Earnings Date	Apr 28, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1...

• Industry: Laboratory Analytical Instruments
• Founded: 1979
• Employees: 1,387
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SBSG

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.